文献速递消化内镜消化道肿瘤与早癌

不同类固醇治疗方案预防内镜黏膜下剥离术后食管狭窄疗效的比较性Meta分析

Efficacy of different steroid therapies in preventing esophageal stricture after endoscopic submucosal dissection: a comparative meta-analysis.
PubMed 文献 · Gastrointest Endosc · 2024-08-22

该比较性Meta分析纳入25项研究、1555例患者,评估不同类固醇给药方式预防浅表性食管癌内镜黏膜下剥离术后食管狭窄的疗效与安全性。结果显示类固醇干预与较低的术后狭窄率和较少的EBD次数相关,联合给药在预防狭窄方面优于单用,但不同给药方式间EBD次数无显著差异。

要点

  • 类固醇干预较无预防组与较低的术后食管狭窄率和较少的EBD次数相关。
  • 预防狭窄的累积排名曲面下面积:SI+OS 98.9% > OS 59.9% > SI 41.2% > CON 0.0%。
  • 各干预不良反应发生率均<10%,多为轻度且停药后可缓解。

核心结论

  • 本研究提示联合给药似乎更适于预防ESD术后食管狭窄,类固醇可改善狭窄预后。
  • 由于缺乏比较不同类固醇给药方式的大样本随机对照试验,未来需更多高质量研究证实这些发现。

研究设计与样本

  • 比较性Meta分析,检索中国知网、万方数据库、PubMed、Embase和Web of Science至2024年3月25日。
  • 共纳入25项研究、1555例患者,治疗策略分为无预防对照组(CON)、类固醇注射(SI)、口服类固醇(OS)及SI联合OS(SI+OS)4组。

主要发现

  • 预防术后食管狭窄的累积排名曲面下面积:SI+OS 98.9% > OS 59.9% > SI 41.2% > CON 0.0%。
  • EBD次数的累积排名曲面下面积:OS 76.9% > SI+OS 62.1% > SI 61.0% > CON 0.0%。
  • 森林图结果提示,与非类固醇组相比,类固醇干预与较低的术后狭窄率和较少的EBD次数相关。
  • SI+OS在预防狭窄方面优于单用SI或OS,不同类固醇给药方式间EBD次数未见显著差异。
  • 所有干预的不良反应发生率均<10%,多为轻度且停药后可缓解。

局限性

  • 原文指出缺乏比较不同类固醇给药方式的大样本随机对照试验。
  • 原文结论提出未来需更多高质量研究证实这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Endoscopic submucosal dissection (ESD) is currently the standard therapy for superficial esophageal cancer (SEC). However, postoperative mucosal defects often lead to esophageal stricture. Although steroid application is effective prophylaxis, the efficacy and safety of various steroid administration modes remain unclear. Thus, this study aimed to evaluate the efficacy and safety of different steroid administrations for SEC patients after ESD. METHODS: A search for relevant studies was conducted on China National Knowledge Infrastructure, Wanfang Database, PubMed, Embase, and Web of Science up to March 25, 2024. Treatment strategies were categorized into 4 groups: no prevention as control (CON), steroid injection (SI), oral steroid (OS), and SI combined with OS (SI+OS). A comparative meta-analysis was conducted to assess outcomes, including postoperative esophageal stricture rate and the number of endoscopic balloon dilation (EBD) sessions required after stricture. RESULTS: A total of 25 studies, involving 1555 patients, were included. The surface under the cumulative rankings were as follows: SI+OS (98.9%) > OS (59.9%) > SI (41.2%) > CON (0.0%) in preventing postoperative esophageal stricture, and OS (76.9%) > SI+OS (62.1%) > SI (61.0%) > CON (0.0%) in the number of EBD sessions required. Forest plot results indicated that compared with the nonsteroid group, steroid interventions were associated with lower rates of postoperative stricture and fewer EBD sessions. Additionally, SI+OS was superior to SI or OS alone in preventing stricture, with no significant differences observed between different steroid administrations in terms of EBD sessions. The incidence of adverse reactions was <10% for all interventions, mostly mild and resolvable upon discontinuation. CONCLUSION: This study suggests that combined administration appears preferable for preventing esophageal stricture in patients after ESD and that steroids could enhance stricture prognosis. However, owing to the lack of large-sample randomized controlled trials comparing different steroid administrations, more high-quality research is necessary to confirm these findings in the future.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Zhou S, Chen X, Feng M, et al. Efficacy of different steroid therapies in preventing esophageal stricture after endoscopic submucosal dissection: a comparative meta-analysis. Gastrointest Endosc. 2024. PMID: 39173780. doi:10.1016/j.gie.2024.08.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。